Skip to main content
Caplight Logo









MyxoTech GmbH

MyxoTech GmbH

Private
SaarbrückenHealthcare & Life Scienceshttps://myxotech.com

Last Round

Grant

Jan 1, 2024

Company Overview

MyxoTech GmbH operates in Healthcare & Life Sciences and is based in Saarbrücken. Its latest recorded funding round was a Grant round in January 2024.

MyxoTech GmbH is a biotechnology company that provides a library of natural products derived from myxobacteria to pharmaceutical companies for drug discovery in indications outside of infectious disease.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MyxoTech GmbH Comparables

Compare MyxoTech GmbH with similar companies based on industry and business-model similarity.

MyxoTech GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kapoose Creek Bio
79%
Generare
78%
Biosortia Microbiomics
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MyxoTech GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 1, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Peter Sullivan

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

MyxoTech GmbH Investors

Notable investors and investment history

MyxoTech GmbH investors
InvestorRounds
Helmholtz AssociationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2024

    Received grant funding from Helmholtz Association.

Book a demo to see all signals

For institutional investors. Book with your work email.

MyxoTech GmbH Filings

Explore SEC and related filing metadata, where available.

MyxoTech GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MyxoTech GmbH's valuation, stock price, and market status.

Is MyxoTech GmbH a public or private company?

MyxoTech GmbH is a private company.

What is the current stock price of MyxoTech GmbH?

MyxoTech GmbH is a private company, so its shares have no public market price. Caplight tracks MyxoTech GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MyxoTech GmbH worth (valuation)?

Valuation information for MyxoTech GmbH is not publicly available.

Can I buy MyxoTech GmbH stock?

MyxoTech GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MyxoTech GmbH's last funding round?

MyxoTech GmbH's most recent funding round was Grant on January 1, 2024.

Who are the main investors in MyxoTech GmbH?

Key investors in MyxoTech GmbH include Helmholtz Association.

Will MyxoTech GmbH IPO soon?

No public IPO plans have been announced for MyxoTech GmbH.

How can I track MyxoTech GmbH secondary market activity?

Caplight tracks bids, offers, and trades in MyxoTech GmbH's shares on secondary markets.

Firmographic Details

HeadquartersSaarbrücken
Employee Range2
Year Founded2024
Last FundingJan 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?